Concepedia
Statistics
Publications
16
Citations
549
H-Index
14
Active since
2001
Affiliations
Antwerp University Hospital(Current)
University of Antwerp
Ablynx (Belgium)
Ghent University Hospital
ZNA Middelheim Hospital
Jolien Van den Bossche is an author at Antwerp University Hospital specializing in medicine, lung cancer, and oncology.
Top concepts
MedicineOncologyLung CancerCell BiologyTumor BiologyRadiation OncologyTumor MicroenvironmentPathologyImmunologyPharmacology
Publications per year
2001–2019
The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer
Christophe Deben, An Wouters, Ken Op de Beeck et al. · Oncotarget · 2015 · 73 citations · Full text
Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress
Christophe Deben, Vanessa Deschoolmeester, Jorrit De Waele et al. · Cancers · 2018 · 63 citations · Full text
Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation
Julie Jacobs, Vanessa Deschoolmeester, Karen Zwaenepoel et al. · OncoImmunology · 2018 · 62 citations · Full text
Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer
Julie Jacobs, Karen Zwaenepoel, Christian Rolfo et al. · Oncotarget · 2015 · 60 citations · Full text
Cancer Immunosurveillance, Novel Immunotherapeutic Target, Medicine +14
APR-246 (PRIMA-1 MET ) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines
Christophe Deben, Filip Lardon, An Wouters et al. · Cancer Letters · 2016 · 59 citations
Prima-1 Met, Parp Inhibition, Medicine +10
1–5 of 16